Emory University is leveraging systematic reviews and machine learning to optimize multi-micronutrient profiles for improved cardiometabolic health. This research identifies nutrient clusters linked to health outcomes, offering potential clinical recommendations.
Emory University is pioneering research to optimize multi-micronutrient profiles that enhance cardiometabolic health. By conducting systematic reviews and meta-analyses, the research aims to establish associations between micronutrients and health outcomes. Using large population-based datasets and unsupervised machine learning, this study will identify clusters of multi-micronutrients that correlate with improved metabolic health. The findings will inform clinical recommendations, offering significant market potential for early adopters in the health and nutrition sectors.
This research currently aligns with Technology Readiness Level 4, as it involves working models and preliminary evidence through systematic reviews. The analysis of population-based data further extends the research to TRL 5, providing initial validation and demonstration of the concept.
Emory University is a comprehensive private research university in Atlanta, anchored by a major academic health center and a mid-sized, research-active faculty. Integration with its academic health system provides direct access to patients, clinicians, and real-world data, enabling rapid clinical translation and large, multisite trials. A hospital-embedded innovation hub and proximity to the CDC and Atlanta’s corporate ecosystem create frequent pathways for co-development, testing, and deployment with industry partners; a long-standing partnership with a neighboring engineering powerhouse broadens prototyping and scale-up options. Research is supported by competitive federal funding, including the National Institutes of Health and the National Science Foundation. A dedicated technology transfer office supports IP strategy, licensing, startup formation, and streamlined industry agreements.